These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1377397)

  • 21. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
    Chandeck Montesa K; Chen Jiménez J; Tamayo JC; Rodríguez Antolín A; Alvarez González E
    Actas Urol Esp; 1992 Mar; 16(3):208-16. PubMed ID: 1621545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of erectile dysfunction with vacuum pumps].
    Derouet H; Zehl U
    Urologe A; 1993 Jul; 32(4):312-5. PubMed ID: 8372414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intracavernous injection of vasoactive substances in the treatment of erectile dysfunction].
    Wehnert J; Kramer J; Weller J; Leike S
    Z Urol Nephrol; 1988 Feb; 81(2):73-8. PubMed ID: 3369250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-injection of papaverine and phentolamine in the treatment of psychogenic impotence.
    Turner LA; Althof SE; Levine SB; Risen CB; Bodner DR; Kursh ED; Resnick MI
    J Sex Marital Ther; 1989; 15(3):163-76. PubMed ID: 2593154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction].
    Porst H
    Urologe A; 1988 Jan; 27(1):22-6. PubMed ID: 3284144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of erection disorders].
    Lycklama à Nijeholt AA
    Ned Tijdschr Geneeskd; 1991 Mar; 135(12):503-4. PubMed ID: 2027393
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of vasoactive agents in the treatment of erectile impotence.
    Fried FA
    N C Med J; 1990 Jun; 51(6):295-6. PubMed ID: 2366889
    [No Abstract]   [Full Text] [Related]  

  • 29. [2 years' experiences with cavernosal autoinjection therapy].
    Stief CG; Thon WF; Scherb W; Gall H; Bähren W
    Urologe A; 1987 Sep; 26(5):294-6. PubMed ID: 2446413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparing effect in the management of erectile dysfunction by using 2 sets of drugs of intracavernosal injection].
    Jian HY; Hao JC
    Zhonghua Nan Ke Xue; 2003 Jun; 9(3):200-1. PubMed ID: 12861835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence].
    Martin-du Pan R
    Rev Med Suisse Romande; 1989 Apr; 109(4):291-8. PubMed ID: 2660216
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances].
    Stief CG; Bähren W; Beckert R; Altwein JE
    J Urol (Paris); 1986; 92(6):349-51. PubMed ID: 3794379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. External vacuum devices in the treatment of erectile dysfunction: a one-year study of sexual and psychosocial impact.
    Turner LA; Althof SE; Levine SB; Bodner DR; Kursh ED; Resnick MI
    J Sex Marital Ther; 1991; 17(2):81-93. PubMed ID: 1920472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twelve-month comparison of two treatments for erectile dysfunction: self-injection versus external vacuum devices.
    Turner LA; Althof SE; Levine SB; Bodner DR; Kursh ED; Resnick MI
    Urology; 1992 Feb; 39(2):139-44. PubMed ID: 1736506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intracavernous self-injection for treatment of erectile dysfunction inpatients with spinal cord injuries].
    Sønksen JO; Hansen EF; Biering-Sørensen F; Colstrup H
    Ugeskr Laeger; 1990 Oct; 152(41):3006-9. PubMed ID: 2238171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term results of corpus cavernosum auto-injection therapy in treatment of patients with chronic erectile dysfunction].
    Gall H; Sparwasser C; Bähren W; Scherb W; Holzki G; Irion R
    Urologe A; 1992 Jan; 31(1):31-6. PubMed ID: 1553802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic injection therapy.
    Zorgniotti AW
    Semin Urol; 1986 Nov; 4(4):233-5. PubMed ID: 3797892
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 39. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of male impotence--a pharmacologic erection program.
    Sanfelippo CJ; Deason AM; Tully AJ; Dennis RL; Leitner WA; Spivey C; Morgan C; Holmes B; Russell RT
    Ala Med; 1988 May; 57(11):17-9. PubMed ID: 3389297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.